Michael Bur
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Inhalation and Respiratory Drug Delivery
- Neonatal Respiratory Health Research
Papers in
-
- Inhalation and Respiratory Drug Delivery 10
- Neonatal Respiratory Health Research 2
-
- Drug Solubulity and Delivery Systems 2
- Advanced Drug Delivery Systems 2
- Co-authors
- Claus‐Michael Lehr (13 shared papers)Stephanie Hein (4 shared papers)Barbara Rothen‐Rutishauser (2 shared papers)Hanno Huwer (3 shared papers)Nicole Schneider‐Daum (2 shared papers)Andrea Lehmann (1 shared paper)Peter Gehr (1 shared paper)Andreas Henning (2 shared papers)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (3 papers)Expert Opinion on Drug Delivery (1 paper)Environmental Science & Technology (1 paper)Alternatives to Laboratory Animals (1 paper)Inhalation Toxicology (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Michael Bur
13 papers receiving 516 citations
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 132
- Pulmonary and Respiratory Medicine 326
- Health, Toxicology and Mutagenesis 78
- Biomaterials 39
- Physiology 58
Countries citing papers authored by Michael Bur
This map shows the geographic impact of Michael Bur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bur more than expected).
Fields of papers citing papers by Michael Bur
This network shows the impact of papers produced by Michael Bur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bur. The network helps show where Michael Bur may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Bur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 112 | |
| 2 | 2009 | 54 | |
| 3 | 2009 | 53 | |
| 4 | 2010 | 50 | |
| 5 | 2006 | 48 | |
| 6 | 2010 | 46 | |
| 7 | 2010 | 43 | |
| 8 | 2008 | 38 | |
| 9 | 2009 | 26 | |
| 10 | 2010 | 25 | |
| 11 | 2008 | 21 | |
| 12 | 2008 | 11 | |
| 13 | 2007 | 3 |
About Michael Bur
Michael Bur is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science, Pediatrics, Perinatology and Child Health, Oncology and Biomaterials, having authored 13 papers that have together received 530 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (10 papers), Drug Solubulity and Delivery Systems (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Advanced Drug Delivery Systems (2 papers), Neonatal Respiratory Health Research (2 papers), Pharmaceutical studies and practices (2 papers) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Pharmaceutical Science (132 citations), Pulmonary and Respiratory Medicine (326 citations), Health, Toxicology and Mutagenesis (78 citations), Biomaterials (39 citations) and Physiology (58 citations). Michael Bur has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Claus‐Michael Lehr, Stephanie Hein, Barbara Rothen‐Rutishauser, Hanno Huwer, Nicole Schneider‐Daum, Andrea Lehmann, Peter Gehr, Andreas Henning, Marc Schneider and Ulrich F. Schaefer. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Expert Opinion on Drug Delivery, Environmental Science & Technology, Alternatives to Laboratory Animals and Inhalation Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.